Introduction

ROCKVILLE, Md., Aug. 14, 2024 /PRNewswire/ — Veridix AI, a part of Emmes Group, has unveiled its innovative protocol digitization capabilities aimed at enhancing the efficiency of clinical trials.

Key Features

• Protocol digitization extracts structured data elements from unstructured text.
• Automates database study builds, reducing build timelines by up to 30%.
• Deployed within 40 study builds across Emmes CRO’s portfolio of projects.
• Future capabilities to include automated eCRF construction.

How Does It Work?

This advanced capability utilizes natural language processing (NLP) techniques combined with AI to convert clinical trial protocols into structured data elements, such as visit schedules and cohorts. The system has been trained on prior clinical trial data, allowing it to generate visit schedules and predict eCRFs with over 82% accuracy.

Impact on Clinical Trials

Clinical trial processes have often been slow and prone to errors. Veridix AI’s new approach aims to streamline these processes, significantly improving data quality and reducing the time required for study builds.

Quotes from Leadership

Rama Kondru, CEO of Veridix AI, stated, “Protocol digitization has the potential to reshape how protocol information is used throughout the clinical research process and ecosystem.” Sastry Chilukuri, CEO of Emmes Group, added, “This unique capability allows us to accelerate the study build process and allows our data managers to focus on value-added work rather than manual, tedious processes.”

About Emmes Group

Emmes Group is a contract research organization (CRO) dedicated to transforming the future of clinical research. Founded over 47 years ago, it has become a leader in clinical research, focusing on technology and AI to deliver faster and more efficient programs.

About Veridix AI

Veridix AI, the technology and AI division of Emmes Group, is committed to advancing AI and patient-centric technologies to expedite clinical trials and bring new treatments to patients more quickly.

Conclusion

With these new capabilities, Veridix AI is setting a new standard in clinical trial efficiency and data quality, paving the way for faster medical discoveries.